STABILIZED ANTI-HEPATITIS B (HBV) ANTIBODY FORMULATIONS

The present invention provides liquid formulations of antibodies or fragments thereof that specifically bind to a hepatitis B virus (HBV) antigen, which formulations exhibit stability, low to undetectable levels of aggregations, and very little to no loss of the biological activities of the antibodi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: EREN RACHEL, O'CONNOR SANDRA, MISRA HEMANT KUMAR, GOWAN WALTER G. JR, DAGAN SHLOMO
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator EREN RACHEL
O'CONNOR SANDRA
MISRA HEMANT KUMAR
GOWAN WALTER G. JR
DAGAN SHLOMO
description The present invention provides liquid formulations of antibodies or fragments thereof that specifically bind to a hepatitis B virus (HBV) antigen, which formulations exhibit stability, low to undetectable levels of aggregations, and very little to no loss of the biological activities of the antibodies or antibody fragments, even during long periods of storage. Furthermore, the invention provides methods of preventing, treating or ameliorating one or more symptoms associated with HBV infection utilizing the liquid formulations of the present invention.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20070122554A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20070122554A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20070122554A3</originalsourceid><addsrcrecordid>eNrjZDAPDnF08vTxjHJ1UXD0C_HU9XANcAzxDPEMVnBS0PBwCtMECzv5u0QquPkH-Yb6AGX9_YJ5GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakm8d5CRgYG5gaGRkampiaMxcaoAzbgo8Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>STABILIZED ANTI-HEPATITIS B (HBV) ANTIBODY FORMULATIONS</title><source>esp@cenet</source><creator>EREN RACHEL ; O'CONNOR SANDRA ; MISRA HEMANT KUMAR ; GOWAN WALTER G. JR ; DAGAN SHLOMO</creator><creatorcontrib>EREN RACHEL ; O'CONNOR SANDRA ; MISRA HEMANT KUMAR ; GOWAN WALTER G. JR ; DAGAN SHLOMO</creatorcontrib><description>The present invention provides liquid formulations of antibodies or fragments thereof that specifically bind to a hepatitis B virus (HBV) antigen, which formulations exhibit stability, low to undetectable levels of aggregations, and very little to no loss of the biological activities of the antibodies or antibody fragments, even during long periods of storage. Furthermore, the invention provides methods of preventing, treating or ameliorating one or more symptoms associated with HBV infection utilizing the liquid formulations of the present invention.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20071231&amp;DB=EPODOC&amp;CC=KR&amp;NR=20070122554A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20071231&amp;DB=EPODOC&amp;CC=KR&amp;NR=20070122554A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>EREN RACHEL</creatorcontrib><creatorcontrib>O'CONNOR SANDRA</creatorcontrib><creatorcontrib>MISRA HEMANT KUMAR</creatorcontrib><creatorcontrib>GOWAN WALTER G. JR</creatorcontrib><creatorcontrib>DAGAN SHLOMO</creatorcontrib><title>STABILIZED ANTI-HEPATITIS B (HBV) ANTIBODY FORMULATIONS</title><description>The present invention provides liquid formulations of antibodies or fragments thereof that specifically bind to a hepatitis B virus (HBV) antigen, which formulations exhibit stability, low to undetectable levels of aggregations, and very little to no loss of the biological activities of the antibodies or antibody fragments, even during long periods of storage. Furthermore, the invention provides methods of preventing, treating or ameliorating one or more symptoms associated with HBV infection utilizing the liquid formulations of the present invention.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAPDnF08vTxjHJ1UXD0C_HU9XANcAzxDPEMVnBS0PBwCtMECzv5u0QquPkH-Yb6AGX9_YJ5GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakm8d5CRgYG5gaGRkampiaMxcaoAzbgo8Q</recordid><startdate>20071231</startdate><enddate>20071231</enddate><creator>EREN RACHEL</creator><creator>O'CONNOR SANDRA</creator><creator>MISRA HEMANT KUMAR</creator><creator>GOWAN WALTER G. JR</creator><creator>DAGAN SHLOMO</creator><scope>EVB</scope></search><sort><creationdate>20071231</creationdate><title>STABILIZED ANTI-HEPATITIS B (HBV) ANTIBODY FORMULATIONS</title><author>EREN RACHEL ; O'CONNOR SANDRA ; MISRA HEMANT KUMAR ; GOWAN WALTER G. JR ; DAGAN SHLOMO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20070122554A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2007</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>EREN RACHEL</creatorcontrib><creatorcontrib>O'CONNOR SANDRA</creatorcontrib><creatorcontrib>MISRA HEMANT KUMAR</creatorcontrib><creatorcontrib>GOWAN WALTER G. JR</creatorcontrib><creatorcontrib>DAGAN SHLOMO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>EREN RACHEL</au><au>O'CONNOR SANDRA</au><au>MISRA HEMANT KUMAR</au><au>GOWAN WALTER G. JR</au><au>DAGAN SHLOMO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>STABILIZED ANTI-HEPATITIS B (HBV) ANTIBODY FORMULATIONS</title><date>2007-12-31</date><risdate>2007</risdate><abstract>The present invention provides liquid formulations of antibodies or fragments thereof that specifically bind to a hepatitis B virus (HBV) antigen, which formulations exhibit stability, low to undetectable levels of aggregations, and very little to no loss of the biological activities of the antibodies or antibody fragments, even during long periods of storage. Furthermore, the invention provides methods of preventing, treating or ameliorating one or more symptoms associated with HBV infection utilizing the liquid formulations of the present invention.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_KR20070122554A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title STABILIZED ANTI-HEPATITIS B (HBV) ANTIBODY FORMULATIONS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T13%3A00%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=EREN%20RACHEL&rft.date=2007-12-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20070122554A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true